ID   GH4C1
AC   CVCL_0276
AS   CVCL_0275
SY   GH(4)C(1); GH4 C 1; GH4-C1; GH4
DR   BTO; BTO:0002767
DR   CLO; CLO_0003485
DR   CLO; CLO_0003490
DR   MCCL; MCC:0000166
DR   MCCL; MCC:0000167
DR   CLDB; cl1459
DR   ATCC; CCL-82.2
DR   ChEMBL-Cells; CHEMBL3307497
DR   ChEMBL-Targets; CHEMBL614572
DR   DSMZ; ACC-482
DR   DSMZCellDive; ACC-482
DR   ICLC; ATL96006
DR   PubChem_Cell_line; CVCL_0276
DR   TOKU-E; 3555
DR   Wikidata; Q54835776
RX   PubMed=218079;
RX   PubMed=1620544;
RX   PubMed=15541569;
WW   https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/g/cell-lines-detail-289.html
CC   Doubling time: ~60-80 hours (DSMZ=ACC-482).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Wistar Furth.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0273 ! GH3
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 23
//
RX   PubMed=218079; DOI=10.1016/S0076-6879(79)58167-1;
RA   Tashjian A.H. Jr.;
RT   "Clonal strains of hormone-producing pituitary cells.";
RL   Methods Enzymol. 58:527-535(1979).
//
RX   PubMed=1620544;
RA   Conrad K.E., Gutierrez-Hartmann A.;
RT   "The ras and protein kinase A pathways are mutually antagonistic in
RT   regulating rat prolactin promoter activity.";
RL   Oncogene 7:1279-1286(1992).
//
RX   PubMed=15541569; DOI=10.1016/j.mce.2004.07.018;
RA   Ooi G.T., Tawadros N., Escalona R.M.;
RT   "Pituitary cell lines and their endocrine applications.";
RL   Mol. Cell. Endocrinol. 228:1-21(2004).
//